Project summary
A multidisciplinary collaboration of leading and emerging clinical vaccine trial researchers, consumers and other stakeholders.
What is the issue for NSW?
The COVID-19 pandemic has highlighted an urgent need to have the capability and infrastructure in NSW to attract and conduct vaccine trials for the benefit of the NSW community, including potential COVID-19 vaccines.
The Alliance will establish NSW as a premier site in Australia for vaccine trial research and support COVID-19 related vaccine clinical trials and beyond.
The Alliance will also work towards scaling up clinical vaccine trials by engaging:
- all NSW LHDs/Sydney Children’s Hospital Network
- private health system
- community health services
- General Practice and
- aged care facilities including rural, remote and regional areas.
What does the research aim to do and how?
- The Waratah Vaccine Alliance will be a centralised ‘one-stop-shop’ for industry and investigators interested in conducting vaccine trials in NSW.
- The Alliance will ensure:
- Collaboration of all NSW vaccine stakeholders in a coordinated approach to vaccine development
- Centralised coordination node for industry and investigators to conduct a vaccine trial in NSW.
- Increase access to clinical vaccine trials for the population of NSW
- Improved trial conduct and population health outcomes
- Provide a forum for consumer involvement and
- Produce the next generation of clinical vaccine trialists.